Picture of Nevro logo

NVRO Nevro News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapTurnaround

U.S. RESEARCH ROUNDUP-Apria, Doordash, Zymergen

Jan 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Apria, Doordash and Zymergen, on Wednesday. 
    
    HIGHLIGHTS
     * Apria Inc  APR.O : UBS cuts to neutral from buy; cuts target price to $37.5 from $41 
     * Doordash Inc  DASH.N : Evercore ISI raises to outperform from in line     
     * Stag Industrial Inc  STAG.N : Baird raises to outperform from neutral 
     * Terreno Realty Corp  TRNO.N : Baird cuts to neutral from outperform 
     * Zymergen Inc  ZY.O : HSBC raises to hold from reduce             
        
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order. 
    
     * 2Seventy Bio Inc  TSVT.O : Wedbush cuts target price to $34 from $41 
     * Activision Blizzard Inc  ATVI.O : Berenberg cuts target price to $100 from $105 
     * Albertsons Companies Inc  ACI.N : JP Morgan raises target price to $38 from $35 
     * American Airlines  AAL.O : Evercore ISI raises target price to $19 from $17 
     * Americold Realty Trust  COLD.N : Baird cuts target price to $34 from $36 
     * Amyris Inc  AMRS.O : HSBC cuts target price to $15 from $16 
     * Apa Corporation  APA.O : Keybanc raises target price to $37 from $33 
     * Applied Genetic Technologies Corp  AGTC.O : Wedbush cuts target price to $9 from $12 
     * Apria Inc  APR.O : UBS cuts to neutral from buy; cuts target price to $37.5 from $41 
     * Aptiv Plc  APTV.N : CFRA raises target price by $5 to $135 
     * Archer-Daniels-Midland Co  ADM.N : JP Morgan assumes with neutral vs overweight rating
     * Archer-Daniels-Midland Co  ADM.N : JP Morgan assumes with $74 vs $76 target price 
     * Beauty Health Co  SKIN.O : Cowen and Company cuts target price to $27 from $32 
     * Beauty Health Co  SKIN.O : Piper Sandler cuts target price to $31 from $33 
     * Bunge Ltd  BG.N : JP Morgan assumes coverage with neutral rating; $94 vs $95 target price 
     * Capstar Financial Holdings Inc  CSTR.O : D.A. Davidson initiates coverage with buy rating 
     * Capstar Financial Holdings Inc  CSTR.O : D.A. Davidson initiates coverage with $26 PT 
     * Civista Bancshares Inc  CIVB.O : D.A. Davidson raises target price to $33 from $31 
     * Civista Bancshares Inc  CIVB.O : Piper Sandler raises target price to $28 from $27.50 
     * Colony Bankcorp Inc  CBAN.O : D.A. Davidson initiates coverage with buy rating and $21 PT
     * Crestwood Equity Partners LP  CEQP.N : UBS cuts target price to $33 from $34 
     * Curtiss-Wright Corp  CW.N : UBS raises target price to $170 from $155 
     * Dexcom Inc  DXCM.O : UBS cuts target price to $640 from $660 
     * Doordash Inc  DASH.N : Evercore ISI adds stock to its tactical action & positioning outperform list
     * Doordash Inc  DASH.N : Evercore ISI raises to outperform from in line 
     * Duke Realty Corp  DRE.N : Baird raises target price to $68 from $67 
     * Eastgroup Properties Inc  EGP.N : Baird raises target price to $212 from $210 
     * EOG Resources Inc  EOG.N : Keybanc raises target price to $108 from $102 
     * First Industrial Realty Trust Inc  FR.N : Baird raises target price to $72 from $70 
     * First Republic Bank  FRC.N : UBS cuts target price to $210 from $211 
     * Gamestop Corp  GME.N : Jefferies cuts target price to $145 from $180 
     * Ginkgo Bioworks Holdings Inc  DNA.N : HSBC raises target price to $15 from $14 
     * IBM  IBM.N : UBS cuts to sell from neutral; cuts target price to $124 from $136 
     * Impinj Inc  PI.O : Canaccord Genuity raises target price to $100 from $95 
     * Indus Realty Trust Inc  INDT.O : Baird raises target price to $81 from $76 
     * Intel Corp  INTC.O : Jefferies raises target price to $51 from $49 
     * Latch Inc  LTCH.O : Berenberg initiates with buy rating; target price $8 
     * Lockheed Martin Corp  LMT.N : UBS raises target price to $410 from $375 
     * Lyft Inc  LYFT.O : Evercore ISI adds stock to its tactical underperformance list 
     * MGM Resorts International  MGM.N : UBS raises target price to $47 from $46 
     * Nasdaq Inc  NDAQ.O : UBS raises target price to $238 from $237 
     * Neogenomics Inc  NEO.O : SVB Leerink cuts target price to $45 from $50 
     * Nevro Corp  NVRO.N : Canaccord Genuity cuts target price to $97 from $118 
     * Nevro Corp  NVRO.N : UBS cuts target price to $94 from $110 
     * Northrop Grumman Corp  NOC.N : UBS raises target price to $405 from $350 
     * Nu Skin Enterprises Inc  NUS.N : Jefferies raises target price to $61 from $60 
     * Philip Morris International Inc  PM.N : UBS raises target price to $95 from $90 
     * Planet Fitness Inc  PLNT.N : D.A. Davidson raises target price to $110 from $105 
     * Prologis Inc  PLD.N : Baird raises target price to $142 from $139 
     * Rada Electronic Industries Ltd  RADA.O : Canaccord Genuity cuts target to $14 from $16 
     * Stag Industrial Inc  STAG.N : Baird cuts target price to $48 from $49 
     * Stag Industrial Inc  STAG.N : Baird raises to outperform from neutral 
     * Sunoco LP  SUN.N : JP Morgan raises target price to $42 from $38 
     * TD Synnex Corp  SNX.N : CFRA raises to buy from hold; raises price target to $133 
     * TD Synnex Corp  SNX.N : Raymond James raises target price to $170 from $150 
     * Terreno Realty Corp  TRNO.N : Baird cuts target price to $79 from $80 
     * Terreno Realty Corp  TRNO.N : Baird cuts to neutral from outperform 
     * Torrid Holdings Inc  CURV.N : Jefferies cuts target price to $20 from $25 
     * Triumph Group Inc  TGI.N : UBS raises target price to $26 from $22 
     * Virgin Galactic Holdings Inc  SPCE.N : UBS cuts target price to $9 from $15 
     * Zymergen Inc  ZY.O : HSBC cuts target price to $6.5 from $8 
     * Zymergen Inc  ZY.O : HSBC raises to hold from reduce 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Nevro

See all news